Erin Cleveland
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Erin Cleveland has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Aldo Pietro Maggioni
Centro Studi ANMCO—Heart Care Foundation, 50121 Florence, Italy
1 shared publication Andrew Bandy
Department of Pathology, Northwestern University,Feinberg School of Medicine,Chicago,IL
1 shared publication- B. R. Bennett
U.S. Naval Research Laboratory, Washington, DC, USA
1 shared publication Baljash Cheema
Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
1 shared publicationBegüm Özel
Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA
1 shared publicationChristina Elizabeth Dancz
Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA
1 shared publication
Latest Publications
- Open Access
- 22 December 2021
- Published by Wiley in Advanced Materials
- Vol. 33 (51) , 2170400
An Axially Continuous Graphene–Copper Wire for High‐Power Transmission: Thermoelectrical Characterization and Mechanisms (Adv. Mater. 51/2021)
- 22 December 2021
- Published by Wiley in Advanced Materials
- Vol. 33 (51) , 2170400
Open AccessAn Axially Continuous Graphene–Copper Wire for High‐Power Transmission: Thermoelectrical Characterization and Mechanisms (Adv. Mater. 51/2021)
- 20 April 2018
- Published by Wolters Kluwer Health in Clinical Liver Disease
- Vol. 11 (4) , 98-104
Diagnostic challenges of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- 20 April 2018
- Published by Wolters Kluwer Health in Clinical Liver Disease
- Vol. 11 (4) , 98-104
Diagnostic challenges of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- 16 November 2017
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 20 (4) , 677-686
Plasma Renin Activity, Response to Aliskiren, and Clinical Outcomes in Patients Hospitalized for Heart Failure: The ASTRONAUT Trial
Aims The direct renin inhibitor, aliskiren, is known to reduce plasma renin activity (PRA), but whether the efficacy of aliskiren varies based on an individual's baseline PRA in patients hospitalized for heart failure (HF) is presently unknown. We characterized the prognostic value of PRA and determined if this risk is modifiable with use of aliskiren. Methods and results This pre‐specified neurohormonal substudy of ASTRONAUT analysed all patients hospitalized for HF with ejection fraction (EF) ≤40% with available baseline PRA data (n = 1306, 80.9%). Risk associated with baseline PRA and short‐term changes in PRA from baseline to 1 month was modelled with respect to 12‐month clinical events. Median baseline PRA was 3.0 (interquartile range 0.6–16.4) ng/mL/h. Aliskiren significantly reduced PRA early after treatment initiation through 12‐month follow‐up compared with placebo (P < 0.001). The lowest baseline PRA quartile (P ≥ 0.43). The prognostic value of baseline PRA and short‐term changes in PRA did not vary by randomization to aliskiren or placebo (interaction P ≥ 0.13). Conclusions Plasma renin activity is reduced early and durably by aliskiren, but this did not translate into improved clinical outcomes in ASTRONAUT. Baseline PRA or short‐term reduction in PRA do not identify a subgroup who may preferentially benefit from direct renin inhibition. Clinical Trial Registration ClinicalTrials.gov Unique Identifier: NCT00894387
- 16 November 2017
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 20 (4) , 677-686
Plasma Renin Activity, Response to Aliskiren, and Clinical Outcomes in Patients Hospitalized for Heart Failure: The ASTRONAUT Trial
Aims The direct renin inhibitor, aliskiren, is known to reduce plasma renin activity (PRA), but whether the efficacy of aliskiren varies based on an individual's baseline PRA in patients hospitalized for heart failure (HF) is presently unknown. We characterized the prognostic value of PRA and determined if this risk is modifiable with use of aliskiren. Methods and results This pre‐specified neurohormonal substudy of ASTRONAUT analysed all patients hospitalized for HF with ejection fraction (EF) ≤40% with available baseline PRA data (n = 1306, 80.9%). Risk associated with baseline PRA and short‐term changes in PRA from baseline to 1 month was modelled with respect to 12‐month clinical events. Median baseline PRA was 3.0 (interquartile range 0.6–16.4) ng/mL/h. Aliskiren significantly reduced PRA early after treatment initiation through 12‐month follow‐up compared with placebo (P < 0.001). The lowest baseline PRA quartile (P ≥ 0.43). The prognostic value of baseline PRA and short‐term changes in PRA did not vary by randomization to aliskiren or placebo (interaction P ≥ 0.13). Conclusions Plasma renin activity is reduced early and durably by aliskiren, but this did not translate into improved clinical outcomes in ASTRONAUT. Baseline PRA or short‐term reduction in PRA do not identify a subgroup who may preferentially benefit from direct renin inhibition. Clinical Trial Registration ClinicalTrials.gov Unique Identifier: NCT00894387
- 1 August 2015
- Published by SAGE Publications in Journal of Gynecologic Surgery
- Vol. 31 (4) , 205-208
Management Considerations for Prolapsed Submucosal Leiomyomata: A Retrospective Cohort Study
- 1 August 2015
- Published by SAGE Publications in Journal of Gynecologic Surgery
- Vol. 31 (4) , 205-208
Management Considerations for Prolapsed Submucosal Leiomyomata: A Retrospective Cohort Study
- Open Access
- 1 December 2014
- Published by AIP Publishing in AIP Advances
- Vol. 4 (12) , 127153
Integration of atomic layer deposited high-k dielectrics on GaSb via hydrogen plasma exposure
In this letter we report the efficacy of a hydrogen plasma pretreatment for integrating atomic layer deposited (ALD) high-k dielectric stacks with device-quality p-type GaSb(001) epitaxial layers. Molecular beam eptiaxy-grown GaSb surfaces were subjected to a 30 minute H2/Ar plasma treatment and subsequently removed to air. High-k HfO2 and Al2O3/HfO2 bilayer insulating films were then deposited via ALD and samples were processed into standard metal-oxide-semiconductor (MOS) capacitors. The quality of the semiconductor/dielectric interface was probed by current-voltage and variable-frequency admittance measurements. Measurement results indicate that the H2-plamsa pretreatment leads to a low density of interface states nearly independent of the deposited dielectric material, suggesting that pre-deposition H2-plasma exposure, coupled with ALD of high-k dielectrics, may provide an effective means for achieving high-quality GaSb MOS structures for advanced Sb-based digital and analog electronics.
- 1 December 2014
- Published by AIP Publishing in AIP Advances
- Vol. 4 (12) , 127153
Open AccessIntegration of atomic layer deposited high-k dielectrics on GaSb via hydrogen plasma exposure
In this letter we report the efficacy of a hydrogen plasma pretreatment for integrating atomic layer deposited (ALD) high-k dielectric stacks with device-quality p-type GaSb(001) epitaxial layers. Molecular beam eptiaxy-grown GaSb surfaces were subjected to a 30 minute H2/Ar plasma treatment and subsequently removed to air. High-k HfO2 and Al2O3/HfO2 bilayer insulating films were then deposited via ALD and samples were processed into standard metal-oxide-semiconductor (MOS) capacitors. The quality of the semiconductor/dielectric interface was probed by current-voltage and variable-frequency admittance measurements. Measurement results indicate that the H2-plamsa pretreatment leads to a low density of interface states nearly independent of the deposited dielectric material, suggesting that pre-deposition H2-plasma exposure, coupled with ALD of high-k dielectrics, may provide an effective means for achieving high-quality GaSb MOS structures for advanced Sb-based digital and analog electronics.
- 8 September 2011
- Published by SPIE-Intl Soc Optical Eng
- Vol. 8106, 81060L-81060L-10
Growth of ZnO nanowires on retroreflector microspheres and the resulting light channeling and plasmonic properties
We have investigated the growth of ZnO nanowires on curved BaTiO3 retroreflector beads, as well as growth of ZnO nanowires on flat substrates. Results indicate that the growth of ZnO aligned nanowire arrays occurs farther away from the Zn source in the retroreflectors, while the results are opposite for the flat Si substrates. In the case of the ZnO nanowires on flat Si, the nanowires formed in nearly aligned arrays are short and significantly thicker, suggesting that the growth occurs both longitudinally and laterally in this process, which is not the case for the growth on the retroreflector beads. The SERS response of the nanowire arrays on the retroreflectors has been compared to random nanowires on flat Si substrates, and results show that the signal strength is 29 times greater in the case of the wires grown on the retroreflectors. Since one would only expect a factor of 4 enhancement due to the light reflecting properties of the retroreflector, it is believed that the enhancement in the SERS signal is due to light channeling by the aligned nanowire arrays.
- 8 September 2011
- Published by SPIE-Intl Soc Optical Eng
- Vol. 8106, 81060L-81060L-10
Growth of ZnO nanowires on retroreflector microspheres and the resulting light channeling and plasmonic properties
We have investigated the growth of ZnO nanowires on curved BaTiO3 retroreflector beads, as well as growth of ZnO nanowires on flat substrates. Results indicate that the growth of ZnO aligned nanowire arrays occurs farther away from the Zn source in the retroreflectors, while the results are opposite for the flat Si substrates. In the case of the ZnO nanowires on flat Si, the nanowires formed in nearly aligned arrays are short and significantly thicker, suggesting that the growth occurs both longitudinally and laterally in this process, which is not the case for the growth on the retroreflector beads. The SERS response of the nanowire arrays on the retroreflectors has been compared to random nanowires on flat Si substrates, and results show that the signal strength is 29 times greater in the case of the wires grown on the retroreflectors. Since one would only expect a factor of 4 enhancement due to the light reflecting properties of the retroreflector, it is believed that the enhancement in the SERS signal is due to light channeling by the aligned nanowire arrays.